ArticleFrontiers in immunology2026

Subsequent treatment strategies following rituximab-resistance in AQP4-IgG+ neuromyelitis optica spectrum disorder: a case series.

Meiqun Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.